Literature DB >> 6098060

Prophylactic antibiotics in transurethral prostatectomy.

N Qvist, H M Christiansen, D Ehlers.   

Abstract

The study included 88 patients with sterile urine prior to transurethral prostatectomy. Forty-five received a preoperative dose of 2 g of cefotaxime (Claforan) and the remaining 43 were given 10 ml of 0.9% NaCl. The two groups did not differ in frequency of postoperative urinary infection (greater than 10(5) colonies per ml urine); 6 patients (13.3%) in the cefotaxime group had postoperative infections during hospital stay as compared to 8 patients (18.6%) in the control group (0.5 greater than p greater than 0.3). Those in the cefotaxime group who had infections were tested for resistance. They were all fully sensitive to cefotaxime except one, who was infected with enterococci. There was no growth of bacteria from either venous blood or bladder irrigating fluid taken during the operations. Nor were any serious complications observed in any of the patients. In view of the relatively low risk of infection and the few side effects of the infections that did occur, prophylactic treatment with an antibiotic is not indicated for transurethral prostatectomy in patients with sterile urine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6098060     DOI: 10.1007/bf00258034

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  9 in total

1.  Systemic antibiotics for prophylaxis in urologic surgery: a critical review.

Authors:  G W Chodak; M E Plaut
Journal:  J Urol       Date:  1979-06       Impact factor: 7.450

2.  Factors reducing the rate of infection after trans-urethral surgery.

Authors:  J M Symes; D G Hardy; K Sutherns; J P Blandy
Journal:  Br J Urol       Date:  1972-10

3.  The value of prophylactic antibiotics in transurethral prostatic resection: a controlled trial, with observations on the origin of postoperative infection.

Authors:  M J Morris; D Golovsky; M D Guinness; P O Maher
Journal:  Br J Urol       Date:  1976-12

4.  Antibacterial activity of cefotaxime.

Authors:  S Mitsuhashi; M Inoue; S Masuyoshi
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

5.  Pharmacokinetics of cefotaxime in normal human volunteers.

Authors:  F Esmieu; J Guibert; H C Rosenkilde; I Ho; A Le Go
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

6.  Prophylactic antibiotics in transurethral prostatectomy.

Authors:  O S Nielsen; S Maigaard; N Frimodt-Møller; P O Madsen
Journal:  J Urol       Date:  1981-07       Impact factor: 7.450

7.  The prophylactic use--or misuse--of antibiotics in transurethral prostatectomy.

Authors:  R P Gibbons; R A Stark; R J Correa; K B Cummings; J T Mason
Journal:  J Urol       Date:  1978-03       Impact factor: 7.450

8.  Short-term prophylaxis with cefotaxime for prostatic surgery.

Authors:  T B Hargreave; J R Hindmarsh; R Elton; G D Chisholm; J C Gould
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-03

9.  Short-term antibiotic prophylaxis and prostatectomy.

Authors:  P J Shah; G Williams; M Chaudary
Journal:  Br J Urol       Date:  1981-08
  9 in total
  4 in total

1.  Assessment of antibiotic prophylaxis prescribing patterns for TURP: A need for Canadian guidelines?

Authors:  Keith A Lawson; Jan K Rudzinski; Ingrid Vicas; Kevin V Carlson
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

Review 2.  Antimicrobial prophylaxis in transurethral surgery.

Authors:  P O Madsen; P H Graversen
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

3.  Comparative evaluation of prophylactic single-dose intravenous antibiotic with postoperative antibiotics in elective urologic surgery.

Authors:  Mohammad K Moslemi; Seyed M Moosavi Movahed; Akram Heidari; Hossein Saghafi; Mehdi Abedinzadeh
Journal:  Ther Clin Risk Manag       Date:  2010-11-09       Impact factor: 2.423

4.  Antibiotic prophylaxis for transurethral urological surgeries: Systematic review.

Authors:  Basim S Alsaywid; Grahame H H Smith
Journal:  Urol Ann       Date:  2013-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.